Overview Money In Money Out People Positions Interview Endorsements
About ICER seeks to provide an independent source of evidence - free from financial conflicts of interest to help patients today and in the future by catalyzing a movement toward fair pricing, fair access, and future innovation across the entire us health care system.
In care of Nixon Peabody LLP
Donations are tax-deductible
Financial Snapshot FY ending 2024-12-31 Financial history 16 17 18 19 20 21 22 23 24
Revenue Expenses
Latest FY2024: $9.2M · Peak FY2017: $15.6M · Avg: $8.1M
Foreign activity (Schedule F) Total spent abroad $156K
Foreign employees 1
Foreign offices 0
Foreign partnership interest No
Foreign trust interest No
Region Activity Spent NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES — —
EVIDENCE FOR HEALTHCARE IMPROVEMENT
Address 14 Beacon Street STE 800
Boston, MA, 02108-370
Governance Voting board members 9
Independent members 9
Conflict-of-interest policy Yes
Whistleblower policy Yes
Doc-retention policy Yes
Audit committee Yes
990 reviewed by board Yes
Compensation practices Severance payments No
Equity-based comp No
Supplemental retirement plan No
Compensation committee Yes
Board approved comp Yes
Initial contract exception Yes
Public records
These open in a new tab. AllCiv doesn't host filings directly — these are the authoritative public-record sources.